
Ryvu Therapeutics Investor Relations Material
Latest events

Study Update
Ryvu Therapeutics

Q1 2025
22 May, 2025

Q4 2024
13 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Ryvu Therapeutics S A
Access all reports
Ryvu Therapeutics S.A. is a Poland-based biotechnology company focused on the research and development of novel small molecule therapies. The company specializes in discovering and developing treatments for cancer, particularly in the areas of targeted therapies and immuno-oncology. Ryvu conducts both early-stage discovery and clinical development activities, with a pipeline supported by internal research capabilities and collaborative partnerships. The company is headquartered in Kraków, Poland, and its shares are listed on the WSE.
Key slides for Ryvu Therapeutics S A


Corporate Presentation
Ryvu Therapeutics S A


Study Update
Ryvu Therapeutics S A
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
RVU
Country
🇵🇱 Poland